Ann: Acadia submits Rett Syndrome New Drug Application to the FDA, page-17

So Acadia have submitted the New Drug Application, and it's up to the FDA to accept it for evaluation. How long does the FDA normally take to confirm it has accepted the application to be evaluated, given we have fast track status and orphan drug designation for trofinetide. And then how long would the FDA take in its assessment before Acadia receives approval to begin producing the drug for commercial sales. I hope these processes happen at better than glacial speeds, especially given the unique status this drug has and the demand from families with children who have this terrible disorder.